Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	52.91	83.4	48.76	94.09	231.64	272.35
Short-Term Investments	262.13	275.04	301.61	295.22	234.18	125.98
Cash & Short-Term Investments	315.05	358.44	350.37	389.31	465.82	398.33
Cash Growth	-4.63%	2.30%	-10.00%	-16.43%	16.94%	30.16%
Accounts Receivable	40.09	36.54	24.09	13.48	15.41	-
Other Receivables	0.3	0.6	0.7	1.1	-	-
Receivables	40.39	37.14	24.79	14.58	15.41	-
Inventory	46.5	39.23	39.71	24.75	19.33	13.93
Prepaid Expenses	6.58	11.22	9.49	13.58	11.71	5.76
Restricted Cash	0.09	0.04	0.12	0.08	0.26	-
Other Current Assets	0.37	0.53	0.33	0.23	0.8	1.42
Total Current Assets	408.97	446.6	424.8	442.54	513.32	419.43
Property, Plant & Equipment	89.45	98.87	116.57	8.56	9.8	10.28
Long-Term Investments	-	-	0.2	-	-	24.38
Other Intangible Assets	4.05	4.36	4.98	6.43	8.4	9.33
Other Long-Term Assets	0.09	0.82	1.52	13.34	11.84	0.25
Total Assets	502.56	550.65	548.06	470.86	543.37	463.66
Accounts Payable	3.31	5.19	4.33	3.09	3.88	2.64
Accrued Expenses	49.39	54.12	50.06	36.28	30.25	22.16
Current Portion of Leases	17.21	15.07	15.6	0.94	1.06	0.79
Current Income Taxes Payable	-	-	-	0.63	0.81	-
Current Unearned Revenue	5.5	11	4.81	3.15	0.19	-
Other Current Liabilities	2.85	12.39	2.39	2.03	4.45	6.41
Total Current Liabilities	78.27	97.76	77.19	46.11	40.65	32
Long-Term Leases	64.62	64.3	82.01	7.15	7.68	7.62
Long-Term Unearned Revenue	12.35	-	-	-	-	-
Other Long-Term Liabilities	12.03	11.11	10.91	12.17	15.95	16.3
Total Liabilities	167.26	173.17	170.11	65.43	64.28	55.91
Common Stock	1,123	1,188	1,200	1,185	1,177	944.33
Additional Paid-In Capital	105.34	127	120.79	85.49	59.01	39.38
Retained Earnings	-891.71	-936.57	-942.32	-864.3	-756.12	-575.16
Comprehensive Income & Other	-0.91	-0.65	-0.73	-1.06	-0.85	-0.81
Shareholders' Equity	335.3	377.48	377.95	405.44	479.09	407.75
Total Liabilities & Equity	502.56	550.65	548.06	470.86	543.37	463.66
Total Debt	81.83	79.37	97.61	8.09	8.74	8.41
Net Cash (Debt)	233.22	279.07	252.76	381.22	457.08	389.92
Net Cash Growth	-4.56%	10.41%	-33.70%	-16.60%	17.22%	27.42%
Net Cash Per Share	1.61	1.91	1.76	2.69	3.53	3.29
Filing Date Shares Outstanding	131.63	137.34	144.62	142.58	141.65	127.45
Total Common Shares Outstanding	132.67	140.88	143.83	142.27	141.6	126.73
Working Capital	330.7	348.83	347.61	396.43	472.68	387.43
Book Value Per Share	2.53	2.68	2.63	2.85	3.38	3.22
Tangible Book Value	331.26	373.12	372.98	399.01	470.69	398.42
Tangible Book Value Per Share	2.50	2.65	2.59	2.80	3.32	3.14
Machinery	2.02	2.02	2.02	1.87	1.88	0.46
Construction In Progress	-	-	-	0.26	0.39	4.47
Leasehold Improvements	3.24	3.24	3.24	2.98	2.98	0.03

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q